Global Pneumonia Vaccine Market Study 2016-2026, by Segment (Pneumococcal Conjugate Vaccine (PCV13) , Pneumococcal Polysaccharide Vaccine (PPSV23)), by Market (Pneumonia , Meningitis , … …), by Company (GlaxoSmithKline , Pfizer , … …)
SKU ID :99ST-14635906 | Published Date: 27-Oct-2019 | No. of pages: 61Description
Summary
The global Pneumonia Vaccine market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Pneumococcal Conjugate Vaccine (PCV13)
Pneumococcal Polysaccharide Vaccine (PPSV23)
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Pneumonia
Meningitis
Sepsis
GlaxoSmithKline
Pfizer
Merck
North America
Europe
Asia-Pacific
South America
Middle East & Africa
The global Pneumonia Vaccine market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Pneumococcal Conjugate Vaccine (PCV13)
Pneumococcal Polysaccharide Vaccine (PPSV23)
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Pneumonia
Meningitis
Sepsis
Company Coverage (Sales data, Main Products & Services etc.):
GlaxoSmithKline
Pfizer
Merck
Major Region
MarketNorth America
Europe
Asia-Pacific
South America
Middle East & Africa
TOC
Tables & Figures
Companies
- PRICE
-
$1800$3600Buy Now